|
Volumn 18, Issue 20, 2004, Pages 51-53
|
India wants to be your biotech source
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE BESYLATE;
AMOXICILLIN PLUS CLAVULANIC ACID;
ANTHRAX VACCINE;
ANTIDIABETIC AGENT;
ANTINEOPLASTIC AGENT;
BETA1A INTERFERON;
DIPHTHERIA PERTUSSIS TETANUS VACCINE;
ECOVAC 4;
HEPATITIS B VACCINE;
INSUGEN;
JAPANESE ENCEPHALITIS VACCINE;
MEASLES VACCINE;
NEUTRAL INSULIN;
NEW DRUG;
NOVOFINE;
NOVOLET;
NP 102;
PRAVASTATIN;
RECOMBINANT HUMAN INSULIN;
TUBERCULOSTATIC AGENT;
UNCLASSIFIED DRUG;
VACCINE;
XEED;
BIOTECHNOLOGY;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
DRUG MANUFACTURE;
HUMAN;
INDIA;
PATENT;
SHORT SURVEY;
ANTHRAX;
JAPANESE ENCEPHALITIS VIRUS;
|
EID: 8844224177
PISSN: 08903670
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (0)
|